AJNA BioSciences: Pioneering Plant-Based Pharmaceuticals | Inside Startup Investing

In this episode, Chris is joined by Joel Stanley, CEO of AJNA BioSciences. Joel discusses his transition from co-founding Charlotte’s Web, a pioneer in the CBD industry, to establishing AJNA BioSciences. He shares the powerful backstory of how his work with CBD began, notably with Charlotte Figi, a young girl whose severe seizures were dramatically reduced using a CBD-rich extract. This episode gets into AJNA BioSciences’ mission to integrate plant-based medicines with modern pharmaceutical practices, emphasizing their current focus on developing botanical drugs for conditions like autism spectrum disorder and anxiety through rigorous FDA-approved clinical trials.
Highlights include…
-Creating FDA-approved drugs from plant medicine for treating conditions like autism and anxiety.
-The decline of plant medicine and its potential revival through modern technology and regulatory changes. (3:53)
-Developing botanical drugs for autism and anxiety disorders, progress and challenges in clinical trials. (8:25)
-Fundraising for Arjuna Biosciences, a biotech company developing cannabinoid-based drugs. (16:16)
-Developing cannabis-based drugs for various diseases, including PTSD and sleep disorders. (20:44)

[@21st-century-business]

Love this discussion!! Where’s the video?